Hi all - I dont post often on HC and prefer to read the (mostly) informative posts by other people, but I do have a question for the science brains out there...
In regards to the Phase II trials (with PMD data being released in December as the first) would the participants have the option to continue with NNZ-2591 after the 12 weeks study?? I know this was the case with the Phase 3 Trof study but assume that this would not be allowed??
The reason I ask is twofold - it would give Neuren further data AND I know how I would feel if my child was on a drug that was working (hopefully really well) only to be taken off this after 12 weeks.
Hi all - I dont post often on HC and prefer to read the (mostly)...
-
- There are more pages in this discussion • 3,569 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.86 |
Change
0.640(3.17%) |
Mkt cap ! $2.666B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $21.10 | $20.39 | $9.299M | 447.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 671 | $20.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.86 | 262 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |